Skip to main content
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.89
+0.35 (2.58%)
At close: Mar 9, 2026, 4:00 PM EDT
13.89
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.62M in the quarter ending December 31, 2025, with 9.76% growth. This brings the company's revenue in the last twelve months to $66.98M, up 0.58% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$66.98M
Revenue Growth
+0.58%
P/S Ratio
6.01
Revenue / Employee
$558,167
Employees
120
Market Cap
403.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ginkgo Bioworks Holdings 170.16M
Niagen Bioscience 129.42M
Autolus Therapeutics 51.13M
Crescent Biopharma 10.84M
PureTech Health 6.39M
Armata Pharmaceuticals 5.05M
Shattuck Labs 1.00M
Revenue Rankings

ENTA News

More News